SCHEMBL16449708

SCHEMBL16449708

Cc1sc(C)c2c1C(=O)CC2=O

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.39
UCHL3 P15374 1/20 0.39
ECE1 P42892 1/20 0.39
MUS81 Q96NY9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853999 0.75 UCHL1 (0.43) UCHL1UCHL3ECE1MUS81
SCHEMBL14217298 0.67 TSHR (0.41)
SCHEMBL8011197 0.66 DRD4 (0.41)
SCHEMBL5262703 0.66 DRD4 (0.45)
SCHEMBL16449706 0.64 MEN1 (0.31)
SCHEMBL1740865 0.63
SCHEMBL15031169 0.63 CASP3 (0.34)
SCHEMBL16284916 0.63
SCHEMBL8960039 0.63
SCHEMBL18020305 0.62 MAPT (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023210772-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND 富士フイルム株式会社 2023-11-02 WO disclosed
US-20170237011-A1 PICENE DERIVATIVE, PHOTOELECTRIC MATERIAL, AND PHOTOELECTRIC DEVICE ADEKA CORPORATION (JP) 2017-08-17 US disclosed
US-20160369045-A1 NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF CORNING INC (US) 2016-12-22 US disclosed
US-20150065722-A1 FUSED THIOPHENE DITIN MONOMERS CORNING INCORPORATED 2015-03-05 US disclosed
US-20150045560-A1 NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF CORNING INCORPORATED 2015-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150065722-A1 FUSED THIOPHENE DITIN MONOMERS TTL, THEM6, ITK UCHL1 2243/4885UCHL3 2250/4885ECE1 4312/4885
US-20150045560-A1 NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF FDPS, PPOX, DHPS UCHL1 2809/4885UCHL3 3145/4885ECE1 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.